Compared to Estimates, UiPath (PATH) Q4 Earnings: A Look at Key Metrics

12.03.25 23:00 Uhr

Werte in diesem Artikel
Aktien

9,58 EUR 0,13 EUR 1,36%

UiPath (PATH) reported $423.65 million in revenue for the quarter ended January 2025, representing a year-over-year increase of 4.5%. EPS of $0.26 for the same period compares to $0.22 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $424.75 million, representing a surprise of -0.26%. The company delivered an EPS surprise of +36.84%, with the consensus EPS estimate being $0.19.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how UiPath performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: ARR: $1.67 billion versus the four-analyst average estimate of $1.67 billion. Net New ARR: $60 million versus the three-analyst average estimate of $65.41 million. Dollar based net retention rate: 110% versus 110.9% estimated by two analysts on average. Revenue- Licenses: $197.61 million versus the four-analyst average estimate of $206.14 million. The reported number represents a year-over-year change of -10.2%. Revenue- Professional Services and other: $10.82 million compared to the $9.73 million average estimate based on four analysts. Revenue- Subscription services: $215.22 million versus the four-analyst average estimate of $208.97 million. View all Key Company Metrics for UiPath here>>>Shares of UiPath have returned -16% over the past month versus the Zacks S&P 500 composite's -8.2% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report UiPath, Inc. (PATH): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: UiPath und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf Q4

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Q4

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu UiPath

Wer­bung